Paradigm Biopharmaceuticals | PAR - Ebit

Stock Price
0.26
Daily Change
-0.01 -1.92%
Monthly
-12.07%
Yearly
-39.29%
Q1 Forecast
0.25

Paradigm Biopharmaceuticals reported AUD-10.31M in EBIT for its fiscal semester ending in June of 2025.





Ebit Change Date
Avita Medical AUD -10.39M 1.72M Dec/2025
Medical Developments International AUD -36K 12.96M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 154.09M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
PYC Therapeutics AUD -22.59M 3.25M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025